- Home
- MYNZ vs DUO Comparison
MYNZ vs DUO Comparison
Compare MYNZ & DUO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MYNZ | DUO |
|---|---|---|
| Founded | 2021 | 2011 |
| Country | Germany | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8M | 6.1M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | MYNZ | DUO |
|---|---|---|
| Price | $1.16 | $1.89 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | ★ 928.5K | 95.7K |
| Earning Date | 12-29-2025 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $659,935.00 | ★ $56,189,313.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.03 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 48.30 |
| 52 Week Low | $0.92 | $1.24 |
| 52 Week High | $8.20 | $24.64 |
Technical Indicators
Market Signals| Indicator | MYNZ | DUO |
|---|---|---|
| Relative Strength Index (RSI) | 43.04 | 45.27 |
| Support Level | $1.00 | $1.78 |
| Resistance Level | $1.13 | $1.92 |
| Average True Range (ATR) | 0.18 | 0.12 |
| MACD | 0.01 | 0.05 |
| Stochastic Oscillator | 20.51 | 89.53 |
Price Performance
Historical ComparisonAbout MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.
About DUO Fangdd Network Group Ltd.
Fangdd Network Group Ltd is an investment holding company. It is engaged in the provision of real estate information services through its online platform which also offers integrated marketing services for individual customers, real estate developers, and agents in China. Its SaaS-based solutions help real estate agents to connect with essential business resources, including customers, property listings, capital, and transaction data. The company generates the majority of its revenue from Base commission from transactions in China.